Wahiba Oualikene

Title: Innovations in Adenoviral Vector Technology by Wahiba Oualikene

Introduction

Wahiba Oualikene is a prominent inventor based in Montrouge, France. She has made significant contributions to the field of adenoviral vector technology, holding a total of 3 patents. Her work focuses on the efficient generation of adenovirus-based libraries and the development of complementary cell lines for adenovirus mutants.

Latest Patents

One of her latest patents is titled "Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease." This invention presents a novel system for generating recombinant adenovirus vectors and expression libraries. It allows for the positive selection of E1-deleted, protease-deleted recombinant adenovirus vectors that include an exogenous gene. The system ensures that only recombinant viral plaques are generated, facilitating the creation of high-purity recombinant adenovirus vectors with a diversity exceeding 10 clones.

Another significant patent involves a "Complementary cell line for the growth of adenovirus mutants with a deleted protease gene." This patent describes a vector/packaging cell line system where vector replication is blocked by the deletion of a single gene, specifically the adenovirus protease gene. The protease is expressed in a complementing cell line through a regulatable expression cassette, enhancing the efficiency of vector generation and propagation while ensuring safety for gene transfer purposes.

Career Highlights

Wahiba Oualikene is currently affiliated with the National Research Council of Canada, where she continues her research and development in adenoviral technologies. Her innovative approaches have positioned her as a key figure in the advancement of gene therapy methodologies.

Collaborations

Throughout her career, Wahiba has collaborated with notable colleagues, including Bernard Massie and Seyyed Mehdy Elahi. These partnerships have contributed to the success and impact of her research in the field.

Conclusion

Wahiba Oualikene's work in adenoviral vector technology exemplifies her commitment to advancing scientific knowledge and innovation. Her patents reflect her expertise and dedication to improving gene transfer methods, making her a valuable contributor to the field.